Signals
When Dementia Takes Speech, Trials Must Catch Up
CervoMed has completed enrolment in a Phase IIa study of neflamapimod in nonfluent/agrammatic primary progressive aphasia. The milestone is small, but the unmet need is not.
Neurology Is Trying to Stop Nerves Dying, Not Just Treat What Is Left
South Sudan Has a New Health Deal. Now It Needs a Delivery System.
AI Improved Sepsis Compliance. Patients Still Need the Outcome Proof.
Cardiac rehab saves lives. Health systems still treat it like optional aftercare
BMI is not enough. Cardiometabolic risk is hiding in where fat lives
MS Has Learnt to Stop Inflammation. It Still Cannot Repair the Damage.
Resistant hypertension may need a diagnostic revolution, not just another drug
When diabetes tech fails, personalised care fails with it
For Drug-Resistant Epilepsy, Surgery Should Not Be the Only Door
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.